Aortopathy_Connective Tissue Disorders

Gene: SLC2A10

Green List (high evidence)

SLC2A10 (solute carrier family 2 member 10)
EnsemblGeneIds (GRCh38): ENSG00000197496
EnsemblGeneIds (GRCh37): ENSG00000197496
OMIM: 606145, Gene2Phenotype
SLC2A10 is in 15 panels

3 reviews

Sangavi Sivagnanasundram (Melbourne Health)

Green List (high evidence)

Classified as Definitive by ClinGen Cardiovascular GCEP on 07/11/2024 - https://search.clinicalgenome.org/CCID:008487

LoF is the mechanism of disease.
Created: 17 Dec 2024, 1:08 a.m. | Last Modified: 17 Dec 2024, 1:08 a.m.
Panel Version: 1.86

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
arterial tortuosity syndrome MONDO:0008818

Publications

  • https://search.clinicalgenome.org/CCID:008487

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

Phenotypes
Arterial tortuosity syndrome MIM#208050

Paul De Fazio (Victorian Clinical Genetics Services)

Green List (high evidence)

"Limited evidence" by ClinGen Aortopathy Working Group:

"The opposite [to COL3A1] holds true for SLC2A10, where there is a high prevalence of aortic enlargement, but the risk for dissection is low based on available data, leading to categorization of SLC2A10 in the additional category B of genes predictive of thoracic aortic enlargement without evidence of progression to aortic dissection."

Many families reported with variants in this gene associated with arterial tortuosity syndrome and Green on PanelApp UK.
Created: 25 Jun 2020, 3:18 a.m. | Last Modified: 25 Jun 2020, 3:18 a.m.
Panel Version: 0.26

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Arterial tortuosity syndrome MIM#606145

Publications

Variants in this GENE are reported as part of current diagnostic practice

History Filter Activity

29 Dec 2020, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: SLC2A10 were changed from Arterial tortuosity syndrome MIM#606145 to Arterial tortuosity syndrome MIM#208050

25 Jun 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: slc2a10 has been classified as Green List (High Evidence).

25 Jun 2020, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: SLC2A10 were changed from to Arterial tortuosity syndrome MIM#606145

25 Jun 2020, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: SLC2A10 were set to

25 Jun 2020, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: SLC2A10 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: SLC2A10 was added gene: SLC2A10 was added to Aortopathy, Connective tissue disorder_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: SLC2A10 was set to Unknown